Citation
Abstract
This systematic review and meta-analysis aims to identify the most frequently reported blood-based biomarkers (BBMs) in randomised controlled trials (RCTs) addressing sarcopenia management, and to perform a preliminary evaluation of the effects of sarcopenia-specific interventions on BBMs concentrations. Medline, Embase and CENTRAL databases were searched to retrieve RCTs published until March 2024 (PROSPERO: CRD42024603238) on older participants with sarcopenia. Eligible studies applied a consensus definition of sarcopenia and reported BBM values before and after intervention. Meta-analyses were performed for BBMs reported in a minimum of 2 RCTs using a random effects model with a standardised mean difference (SMD) and a 95% confidence interval. Among 58 RCTs on sarcopenia management, only 21 (36.2%) assessed BBMs and none involved pharmacological interventions. Altogether, 47 distinct BBMs were identified. The most frequently reported were C-reactive protein, interleukin 6, tumour necrosis factor α, Insulin-like Growth Factor 1 (IGF-1). Muscle-specific BBM, follistatin, growth differentiation factor 8 and 15 were assessed in only 2 RCTs. Among non-muscle-specific BBMs, IGF-1 was significantly impacted by the studied interventions (SMD = 0.46, CI = [0.04; 0.88]). However, this change was not significant when analyses were restricted to RCTs reporting significant improvement in key sarcopenia measures. Despite substantial heterogeneity, few BBMs assessed in sarcopenia RCTs were muscle-specific and limited biomarkers responded to interventions. There is an urgent need to adopt recommendations regarding muscle-specific BBMs to be assessed in sarcopenia RCTs. Developing a standardised Core Outcome Set for sarcopenia intervention studies would enhance the standardisation of sarcopenia RCTs and ultimately improve disease management.
Download File
Official URL or Download Paper: https://onlinelibrary.wiley.com/doi/10.1111/acel.7...
|
Additional Metadata
| Item Type: | Article |
|---|---|
| Subject: | Aging |
| Subject: | Cell Biology |
| Divisions: | Faculty of Medicine and Health Science Malaysian Research Institute on Ageing |
| DOI Number: | https://doi.org/10.1111/acel.70361 |
| Publisher: | John Wiley and Sons |
| Keywords: | Biomarkers; Meta-analysis; Randomised controlled trials; Reference standards; Sarcopenia |
| Depositing User: | MS. HADIZAH NORDIN |
| Date Deposited: | 10 Mar 2026 02:42 |
| Last Modified: | 10 Mar 2026 02:42 |
| Altmetrics: | http://www.altmetric.com/details.php?domain=psasir.upm.edu.my&doi=10.1111/acel.70361 |
| URI: | http://psasir.upm.edu.my/id/eprint/123451 |
| Statistic Details: | View Download Statistic |
Actions (login required)
![]() |
View Item |
